Efficacy News and Research

RSS
Novel indirect screener can identify women at risk for illicit drug use

Novel indirect screener can identify women at risk for illicit drug use

FEIBA drug safe and effective for patients with hemophilia A

FEIBA drug safe and effective for patients with hemophilia A

MSCs can be reprogrammed to have enhanced survival and therapeutic efficacy

MSCs can be reprogrammed to have enhanced survival and therapeutic efficacy

Promedior's Pentraxin-2 effectively suppresses liver fibrosis

Promedior's Pentraxin-2 effectively suppresses liver fibrosis

Viewpoints: GOP intransigence on super committee; taxing health benefits would backfire; the need for care in defining essential benefits

Viewpoints: GOP intransigence on super committee; taxing health benefits would backfire; the need for care in defining essential benefits

AVEO third quarter net loss increases to $23.8 million

AVEO third quarter net loss increases to $23.8 million

NovaSterilis reports significant findings from sterilization of absorbable suture study

NovaSterilis reports significant findings from sterilization of absorbable suture study

Pharmasset initiates PSI-7977 Phase 3 program for HCV

Pharmasset initiates PSI-7977 Phase 3 program for HCV

Ultra-sensitive techniques for early detection of breast cancer

Ultra-sensitive techniques for early detection of breast cancer

BUSM professor delivers Van Meter Award Lecture at 81st ATA meeting

BUSM professor delivers Van Meter Award Lecture at 81st ATA meeting

Studies on effectiveness of new HCV therapies presented at 76th ACG meeting

Studies on effectiveness of new HCV therapies presented at 76th ACG meeting

NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

NPS announces new data from GATTEX Phase 3 study on short bowel syndrome

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

'Good bugs' promising against ulcerative colitis, psoriasis, chronic fatigue syndrome

'Good bugs' promising against ulcerative colitis, psoriasis, chronic fatigue syndrome

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

YM BioSciences announces results of nimotuzumab Phase II study on DIPG

YM BioSciences announces results of nimotuzumab Phase II study on DIPG

PPRT publishes study that evaluates pharmacist provision of clozapine

PPRT publishes study that evaluates pharmacist provision of clozapine

Pacira's third quarter total revenues decrease to $4.0 million

Pacira's third quarter total revenues decrease to $4.0 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.